Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Patricia Macanas-Pirard"'
Autor:
Sebastián Mondaca, Benjamín Walbaum, Nicole Le Corre, Marcela Ferrés, Alejandro Valdés, Constanza Martínez-Valdebenito, Cinthya Ruiz-Tagle, Patricia Macanas-Pirard, Patricio Ross, Betzabé Cisternas, Patricia Pérez, Olivia Cabrera, Valentina Cerda, Ivana Ormazábal, Aldo Barrera, María E. Prado, María I. Venegas, Silvia Palma, Richard Broekhuizen, Alexis M. Kalergis, Susan M. Bueno, Manuel A. Espinoza, M. Elvira Balcells, Bruno Nervi
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1193 (2023)
Cancer patients on chemotherapy have a lower immune response to SARS-CoV-2 vaccines. Therefore, through a prospective cohort study of patients with solid tumors receiving chemotherapy, we aimed to determine the immunogenicity of an mRNA vaccine boost
Externí odkaz:
https://doaj.org/article/a5e1d3e1d8ac4049914fc4baeb82e025
Autor:
Patricia Macanas-Pirard, Thomas Quezada, Leonardo Navarrete, Richard Broekhuizen, Andrea Leisewitz, Bruno Nervi, Pablo A Ramírez
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0168888 (2017)
Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection a
Externí odkaz:
https://doaj.org/article/79800eaacf264161be14c6f5b3b3a422
Autor:
Patricia Macanas-Pirard, Andrea Leisewitz, Richard Broekhuizen, Kelly Cautivo, Francisco M Barriga, Francisco Leisewitz, Victoria Gidi, Erick Riquelme, Viviana P Montecinos, Pilar Swett, Pelayo Besa, Pablo Ramirez, Mauricio Ocqueteau, Alexis M Kalergis, Matthew Holt, Michael Rettig, John F DiPersio, Bruno Nervi
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e37203 (2012)
BACKGROUND: Despite a high response rate to chemotherapy, the majority of patients with acute myeloid leukemia (AML) are destined to relapse due to residual disease in the bone marrow (BM). The tumor microenvironment is increasingly being recognized
Externí odkaz:
https://doaj.org/article/ac58465ead124ae08d7178bf23733a40
Autor:
Nervi, Sebastián Mondaca, Benjamín Walbaum, Nicole Le Corre, Marcela Ferrés, Alejandro Valdés, Constanza Martínez-Valdebenito, Cinthya Ruiz-Tagle, Patricia Macanas-Pirard, Patricio Ross, Betzabé Cisternas, Patricia Pérez, Olivia Cabrera, Valentina Cerda, Ivana Ormazábal, Aldo Barrera, María E. Prado, María I. Venegas, Silvia Palma, Richard Broekhuizen, Alexis M. Kalergis, Susan M. Bueno, Manuel A. Espinoza, M. Elvira Balcells, Bruno
Publikováno v:
Vaccines; Volume 11; Issue 7; Pages: 1193
Cancer patients on chemotherapy have a lower immune response to SARS-CoV-2 vaccines. Therefore, through a prospective cohort study of patients with solid tumors receiving chemotherapy, we aimed to determine the immunogenicity of an mRNA vaccine boost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::5dab5bd6b88df5579240bfb56e618561
Autor:
Hardev S. Pandha, Ruth Pettengell, Jastinder Sohal, Liesl Shears, Patricia Macanas Pirard, Richard Morgan
Supplementary Figure Legend from Antagonism of HOX/PBX Dimer Formation Blocks the In vivo Proliferation of Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01cc5c08c6426044412ad4ddc7a07ee
https://doi.org/10.1158/0008-5472.22367579.v1
https://doi.org/10.1158/0008-5472.22367579.v1
Autor:
Hardev S. Pandha, Ruth Pettengell, Jastinder Sohal, Liesl Shears, Patricia Macanas Pirard, Richard Morgan
Malignant melanoma is a cancer that arises from melanocyte cells in a complex but well-studied process, and which can only be successfully treated prior to metastasis as it is highly resistant to conventional therapies. A number of recent reports hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4efa97563b6ba9456d4385fdc668bb3b
https://doi.org/10.1158/0008-5472.c.6495611
https://doi.org/10.1158/0008-5472.c.6495611
Autor:
Patricia Macanas-Pirard, Pablo Ramirez, Bruno Nervi, Richard Broekhuizen, Patricia García, Alfonso González, Mauricio Ocqueteau, Daniel Ernst, Claudia Oyanadel, Felipe A. Court, Viviana P. Montecinos
Publikováno v:
Oncotarget
The interaction between acute myeloid leukemia cells (AML) with the bone marrow stroma cells (BMSCs) determines a protective environment that favors tumor development and resistance to conventional chemotherapy. We showed that BMSCs secrete soluble f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f623fc33cce32917b416770c8408aec7
https://doi.org/10.18632/oncotarget.14981
https://doi.org/10.18632/oncotarget.14981
Autor:
Bruno Nervi, Patricia Macanas-Pirard, Thomas Quezada, Pablo Ramirez, Andrea V. Leisewitz, Richard Broekhuizen, Leonardo Navarrete
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 1, p e0168888 (2017)
PLoS ONE, Vol 12, Iss 1, p e0168888 (2017)
Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19daee3cc8b01a9fe6fa0faf869a0f87
http://europepmc.org/articles/PMC5207636
http://europepmc.org/articles/PMC5207636
Autor:
Sergio Vargas-Salas, Bruno Nervi, Vivianne Torres, Juan Carlos Roa, Sabrina Muñiz-Muñoz, Carolina Bizama, Patricia Macanas-Pirard, Francisco Melo, Viviana P. Montecinos, Daniel Ernst, Richard Broekhuizen, Romina Coronado
Publikováno v:
Journal of Clinical Oncology. 37:e18500-e18500
e18500 Background: The interaction of acute myeloid leukemia (AML) with the bone marrow stroma (BMS) determines a protective microenvironment that favors leukemia development and resistance to chemotherapy. We developed an in vitro platform to study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ac85458605e4ebd15a7f06f0d97766f
https://doi.org/10.1200/jco.2019.37.15_suppl.e18500
https://doi.org/10.1200/jco.2019.37.15_suppl.e18500
Autor:
Ayaz Mehar, Yutaka Takahashi, Patricia Macanas-Pirard, Helen M. Coley, Georges E. N. Kass, Atsushi Mizokami
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 324:1181-1187
Cyclooxygenase (COX)-2 has emerged as an exciting target for therapeutic intervention in the management of cancer. Immunohistochemistry studies have indicated higher expression of COX-2 in cancerous versus benign prostatic tissue. We have explored th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f3da78f20e0e841dcc1f488fff1fcd
https://doi.org/10.1124/jpet.107.131383
https://doi.org/10.1124/jpet.107.131383